Japan
· Delayed Price · Currency is JPY ReproCELL Statistics
Total Valuation
ReproCELL has a market cap or net worth of JPY 14.30 billion. The enterprise value is 9.87 billion.
| Market Cap | 14.30B |
| Enterprise Value | 9.87B |
Important Dates
The next estimated earnings date is Wednesday, May 14, 2025.
| Earnings Date | May 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ReproCELL has 94.70 million shares outstanding. The number of shares has increased by 7.07% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 94.70M |
| Shares Change (YoY) | +7.07% |
| Shares Change (QoQ) | +1.03% |
| Owned by Insiders (%) | 5.16% |
| Owned by Institutions (%) | 5.76% |
| Float | 89.35M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.26 |
| PB Ratio | 1.61 |
| P/TBV Ratio | 1.61 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -89.72 |
| EV / Sales | 3.63 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.41
| Current Ratio | 2.41 |
| Quick Ratio | 2.18 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -1.32% and return on invested capital (ROIC) is -2.26%.
| Return on Equity (ROE) | -1.32% |
| Return on Assets (ROA) | -1.92% |
| Return on Invested Capital (ROIC) | -2.26% |
| Return on Capital Employed (ROCE) | -3.37% |
| Revenue Per Employee | 28.31M |
| Profits Per Employee | -1.15M |
| Employee Count | 96 |
| Asset Turnover | 0.28 |
| Inventory Turnover | 4.21 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +8.63% in the last 52 weeks. The beta is 0.79, so ReproCELL's price volatility has been lower than the market average.
| Beta (5Y) | 0.79 |
| 52-Week Price Change | +8.63% |
| 50-Day Moving Average | 158.86 |
| 200-Day Moving Average | 131.35 |
| Relative Strength Index (RSI) | 53.73 |
| Average Volume (20 Days) | 2,308,885 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ReproCELL had revenue of JPY 2.72 billion and -110.00 million in losses. Loss per share was -1.21.
| Revenue | 2.72B |
| Gross Profit | 1.42B |
| Operating Income | -301.00M |
| Pretax Income | -111.00M |
| Net Income | -110.00M |
| EBITDA | -274.00M |
| EBIT | -301.00M |
| Loss Per Share | -1.21 |
Balance Sheet
The company has 4.43 billion in cash and n/a in debt, giving a net cash position of 4.43 billion or 46.78 per share.
| Cash & Cash Equivalents | 4.43B |
| Total Debt | n/a |
| Net Cash | 4.43B |
| Net Cash Per Share | 46.78 |
| Equity (Book Value) | 8.89B |
| Book Value Per Share | 94.36 |
| Working Capital | 3.23B |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 52.06%, with operating and profit margins of -11.07% and -4.05%.
| Gross Margin | 52.06% |
| Operating Margin | -11.07% |
| Pretax Margin | -4.08% |
| Profit Margin | -4.05% |
| EBITDA Margin | -10.08% |
| EBIT Margin | -11.07% |
| FCF Margin | n/a |
Dividends & Yields
ReproCELL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.07% |
| Shareholder Yield | -7.07% |
| Earnings Yield | -0.77% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on August 28, 2013. It was a forward split with a ratio of 5.
| Last Split Date | Aug 28, 2013 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
ReproCELL has an Altman Z-Score of 3.63.
| Altman Z-Score | 3.63 |
| Piotroski F-Score | n/a |